Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 56

    1.

    Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.

    Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ; EVENT Registry Investigators.

    JACC Cardiovasc Interv. 2009 Nov;2(11):1074-82.PMID: 19926047 [PubMed - in process]Related articles

    2.

    Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry.

    Philipp S, Böse D, Wijns W, Marso SP, Schwartz RS, König A, Lerman A, Garcia-Garcia HM, Serruys PW, Erbel R.

    Eur Heart J. 2009 Oct 23. [Epub ahead of print]PMID: 19854730 [PubMed - as supplied by publisher]Related articles

    3.

    Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).

    Frutkin AD, Lindsey JB, Mehta SK, House JA, Spertus JA, Cohen DJ, Rumsfeld JS, Marso SP; NCDR (National Cardiovascular Data Registry).

    JACC Cardiovasc Interv. 2009 Jul;2(7):614-21.PMID: 19628183 [PubMed - indexed for MEDLINE]Related articles

    4.

    Chronic total occlusion angioplasty in the United States.

    Grantham JA, Marso SP, Spertus J, House J, Holmes DR Jr, Rutherford BD.

    JACC Cardiovasc Interv. 2009 Jun;2(6):479-86. Review.PMID: 19539249 [PubMed - indexed for MEDLINE]Related articles

    5.

    Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel.

    Safley DM, House JA, Marso SP, Grantham JA, Rutherford BD.

    JACC Cardiovasc Interv. 2008 Jun;1(3):295-302.PMID: 19463316 [PubMed - indexed for MEDLINE]Related articles

    6.

    Diabetes and drug-eluting stents: what you get and what you don't.

    Marso SP.

    JACC Cardiovasc Interv. 2008 Apr;1(2):148-9. No abstract available. PMID: 19463292 [PubMed - indexed for MEDLINE]Related articles

    7.

    Steatosis and diastolic dysfunction: the skinny on myocardial fat.

    Lindsey JB, Marso SP.

    J Am Coll Cardiol. 2008 Nov 25;52(22):1800-2. No abstract available. PMID: 19022159 [PubMed - indexed for MEDLINE]Related articles

    8.

    Suitability of saphenous vein graft lesions for the use of distal embolic protection devices.

    Mehta SK, Stolker JM, Frutkin AD, Marso SP.

    J Invasive Cardiol. 2008 Nov;20(11):568-70.PMID: 18987394 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Vulnerable plaque intervention: State of the art.

    Young JJ, Phillips HR, Marso SP, Granada JF, McPherson JA, Waksman R, Steinhubl SR, Schwartz RS, Stone GW.

    Catheter Cardiovasc Interv. 2008 Feb 15;71(3):367-74. Review.PMID: 18288729 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.

    Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA.

    Circulation. 2008 Feb 26;117(8):1018-27. Epub 2008 Feb 11.PMID: 18268145 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries.

    Marso SP, Mehta SK, Frutkin A, House JA, McCrary JR, Kulkarni KR.

    Diabetes Care. 2008 May;31(5):989-94. Epub 2008 Feb 5.PMID: 18252902 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Outcomes of 1,090 consecutive, elective, nonselected percutaneous coronary interventions at a community hospital without onsite cardiac surgery.

    Frutkin AD, Mehta SK, Patel T, Menon P, Safley DM, House J, Barth CW 3rd, Grantham JA, Marso SP.

    Am J Cardiol. 2008 Jan 1;101(1):53-7.PMID: 18157965 [PubMed - indexed for MEDLINE]Related articles

    13.

    Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).

    Mehta SK, Frutkin AD, Milford-Beland S, Klein LW, Shaw RE, Weintraub WS, Krone RJ, Anderson HV, Kutcher MA, Marso SP; American College of Cardiology-National Cardiovascular Data Registry.

    Am J Cardiol. 2007 Oct 1;100(7):1114-8. Epub 2007 Jul 18.PMID: 17884373 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).

    Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW.

    Am J Cardiol. 2007 Jul 15;100(2):206-10. Epub 2007 Jun 4.PMID: 17631071 [PubMed - indexed for MEDLINE]Related articles

    15.

    Limitations to the use of virtual histology-intravascular ultrasound to detect vulnerable plaque.

    Frutkin AD, Mehta SK, McCrary JR, Marso SP.

    Eur Heart J. 2007 Jul;28(14):1783-4. Epub 2007 May 8. No abstract available. PMID: 17488759 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque.

    Mehta SK, McCrary JR, Frutkin AD, Dolla WJ, Marso SP.

    Eur Heart J. 2007 Jun;28(11):1283-8. Epub 2007 May 5. Review.PMID: 17483541 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The editor's roundtable: intravascular ultrasonic imaging of the coronary arteries.

    Friedewald VE, Marso SP, Tuzcu EM, Weissman NJ, Roberts WC.

    Am J Cardiol. 2007 Apr 1;99(7):943-50; quiz 950. Epub 2007 Feb 15. No abstract available. PMID: 17398189 [PubMed - indexed for MEDLINE]Related articles

    18.

    Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization.

    Safley DM, House JA, Laster SB, Daniel WC, Spertus JA, Marso SP.

    Circulation. 2007 Feb 6;115(5):569-75. Epub 2007 Jan 22.PMID: 17242281 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology.

    Marso SP, House JA, Hopkins PJ.

    Int J Immunogenet. 2006 Oct;33(5):347-54.PMID: 16984279 [PubMed - indexed for MEDLINE]Related articles

    20.

    Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome population.

    Marso SP, Safley DM, House JA, Tessendorf T, Reid KJ, Spertus JA.

    Diabetes Care. 2006 Aug;29(8):1931-2. No abstract available. PMID: 16873808 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Success rates of percutaneous coronary intervention of chronic total occlusions and long-term survival in patients with diabetes mellitus.

    Safley DM, House JA, Rutherford BD, Marso SP.

    Diab Vasc Dis Res. 2006 May;3(1):45-51.PMID: 16784181 [PubMed - indexed for MEDLINE]Related articles

    22.

    Peripheral arterial disease in patients with diabetes.

    Marso SP, Hiatt WR.

    J Am Coll Cardiol. 2006 Mar 7;47(5):921-9. Epub 2006 Feb 9. Review.PMID: 16516072 [PubMed - indexed for MEDLINE]Related articles

    23.

    Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome.

    Safley DM, Marso SP.

    Diab Vasc Dis Res. 2005 Oct;2(3):128-35. Review.PMID: 16334594 [PubMed - indexed for MEDLINE]Related articles

    24.

    Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention.

    Marso SP, Murphy JW, House JA, Safley DM, Harris WS.

    Diab Vasc Dis Res. 2005 Feb;2(1):31-6.PMID: 16305070 [PubMed - indexed for MEDLINE]Related articles

    25.

    Diabetes mellitus and vascular risk: continuing the quest for the elusive keystone.

    Marso SP.

    Diab Vasc Dis Res. 2005 Feb;2(1):7-8. No abstract available. PMID: 16305066 [PubMed - indexed for MEDLINE]Related articles

    26.

    Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

    Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr.

    J Am Coll Cardiol. 2005 Sep 6;46(5):821-6.PMID: 16139131 [PubMed - indexed for MEDLINE]Related articles

    27.

    Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction.

    Corpus RA, House JA, Marso SP, Grantham JA, Huber KC Jr, Laster SB, Johnson WL, Daniels WC, Barth CW, Giorgi LV, Rutherford BD.

    Am Heart J. 2004 Sep;148(3):493-500.PMID: 15389238 [PubMed - indexed for MEDLINE]Related articles

    28.

    Improving the pharmacological regimen for patients with diabetes mellitus.

    Marso SP.

    Rev Cardiovasc Med. 2004 Summer;5(3):139-47. Review.PMID: 15346097 [PubMed - indexed for MEDLINE]Related articles

    29.

    Diabetes and percutaneous coronary revascularization in the drug-eluting stent era.

    Safley DM, Marso SP.

    Herz. 2004 Aug;29(5):542-50. Review.PMID: 15340741 [PubMed - indexed for MEDLINE]Related articles

    30.

    Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes.

    Srichai MB, Jaber WA, Prior DL, Marso SP, Houghtaling PL, Menon V, Simoons ML, Harrington RA, Hochman JS; PURSUIT Investigators.

    Am Heart J. 2004 Jan;147(1):84-90.PMID: 14691424 [PubMed - indexed for MEDLINE]Related articles

    31.

    Improving in-hospital mortality in the setting of an increasing risk profile among patients undergoing catheter-based reperfusion for an acute myocardial infarction without cardiogenic shock.

    Marso SP, Gowda M, O'Keefe JH, Coen MM, McCallister BD, Giorgi LV, Huber KC, Laster SB, Johnson WL, Rutherford BD.

    J Invasive Cardiol. 2003 Dec;15(12):711-6.PMID: 14660825 [PubMed - indexed for MEDLINE]Related articles

    32.

    Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality.

    Marso SP, Bliven BD, House JA, Muehlebach GF, Borkon AM.

    Eur Heart J. 2003 Jul;24(14):1323-8.PMID: 12871689 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease.

    Shishehbor MH, Hoogwerf BJ, Schoenhagen P, Marso SP, Sun JP, Li J, Klein AL, Thomas JD, Garcia MJ.

    Am J Cardiol. 2003 Jun 15;91(12):1514-7, A9. No abstract available. PMID: 12804750 [PubMed - indexed for MEDLINE]Related articles

    34.

    Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury.

    Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol EJ.

    Circulation. 2003 May 6;107(17):2238-43. Epub 2003 Apr 28.PMID: 12719284 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Central role of RAGE-dependent neointimal expansion in arterial restenosis.

    Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y.

    J Clin Invest. 2003 Apr;111(7):959-72.PMID: 12671045 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years.

    Marso SP, Giorgi LV, Johnson WL, Huber KC, Laster SB, Shelton CJ, McCallister BD, Coen MM, Rutherford BD.

    Am Heart J. 2003 Feb;145(2):270-7.PMID: 12595844 [PubMed - indexed for MEDLINE]Related articles

    37.

    An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial.

    Cho L, Bhatt DL, Marso SP, Brennan D, Holmes DR Jr, Califf RM, Topol EJ.

    Am J Med. 2003 Feb 1;114(2):106-11.PMID: 12586229 [PubMed - indexed for MEDLINE]Related articles

    38.

    A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass.

    Borkon AM, Muehlebach GF, House J, Marso SP, Spertus JA.

    Ann Thorac Surg. 2002 Nov;74(5):1526-30; discussion 1530.PMID: 12440603 [PubMed - indexed for MEDLINE]Related articles

    39.

    Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.

    Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ.

    Am J Cardiol. 2002 Sep 15;90(6):625-8. No abstract available. PMID: 12231089 [PubMed - indexed for MEDLINE]Related articles

    40.

    Optimizing the diabetic formulary: beyond aspirin and insulin.

    Marso SP.

    J Am Coll Cardiol. 2002 Aug 21;40(4):652-61. Review.PMID: 12204494 [PubMed - indexed for MEDLINE]Related articles

    41.

    Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.

    Labinaz M, Kilaru R, Pieper K, Marso SP, Kitt MM, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA.

    Circulation. 2002 Jan 22;105(3):322-7.PMID: 11804987 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.

    Park SH, Marso SP, Zhou Z, Foroudi F, Topol EJ, Lincoff AM.

    Circulation. 2001 Aug 14;104(7):815-9.PMID: 11502708 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience.

    Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV, Johnson WL, Rutherford BD.

    J Am Coll Cardiol. 2001 Aug;38(2):409-14.PMID: 11499731 [PubMed - indexed for MEDLINE]Related articles

    44.

    Optimizing percutaneous coronary revascularization in diabetic women: analysis from the EPISTENT trial.

    Cho L, Marso SP, Bhatt DL, Topol EJ.

    J Womens Health Gend Based Med. 2000 Sep;9(7):741-6.PMID: 11025866 [PubMed - indexed for MEDLINE]Related articles

    45.

    Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy.

    Dyke CM, Bhatia D, Lorenz TJ, Marso SP, Tardiff BE, Hogeboom C, Harrington RA.

    Ann Thorac Surg. 2000 Sep;70(3):866-71; discussion 871-2.PMID: 11016325 [PubMed - indexed for MEDLINE]Related articles

    46.

    Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting.

    Marso SP, Ellis SG, Gurm HS, Lytle BW, Topol EJ.

    Am Heart J. 2000 Jun;139(6):939-44.PMID: 10827372 [PubMed - indexed for MEDLINE]Related articles

    47.

    Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

    Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ.

    J Am Coll Cardiol. 2000 Mar 15;35(4):922-8.PMID: 10732889 [PubMed - indexed for MEDLINE]Related articles

    48.

    Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators.

    Marso SP, Bhatt DL, Roe MT, Houghtaling PL, Labinaz M, Kleiman NS, Dyke C, Simmoons ML, Califf RM, Harrington RA, Topol EJ.

    Circulation. 2000 Dec 12;102(24):2952-8.PMID: 11113045 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT]).]

    Robbins MA, Marso SP, Wolski K, Peterson J, Lincoff AM, Brener S.

    Am J Cardiol. 1999 Dec 1;84(11):1350-3, A8.PMID: 10614805 [PubMed - indexed for MEDLINE]Related articles

    50.

    Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.

    Marso SP, Lincoff AM, Ellis SG, Bhatt DL, Tanguay JF, Kleiman NS, Hammoud T, Booth JE, Sapp SK, Topol EJ.

    Circulation. 1999 Dec 21-28;100(25):2477-84.PMID: 10604884 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...